Some research suggests that those already genetically predisposed to developing dementia could benefit from fish oil ...

The calling card of Alzheimer’s disease is a buildup of misfolded amyloid protein in the brain, but many medicines struggle ...

A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein may not lead to meaningful improvements for patients.

Scientists in Japan found that arginine, a common amino acid already used in supplements and medicine, reduced harmful ...

Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually ...

India is set to receive its first disease-modifying Alzheimer’s therapy as Eli Lilly prepares to launch Donanemab under the brand name Lormalzi.

Eli Lilly’s new drug targets the pathophysiology of Alzheimer’s to slow progression of disease; price point and side effects ...

Scientists have discovered a way to help the brain clean itself of harmful Alzheimer’s plaques by activating its own support cells. By increasing a protein called Sox9, researchers were able to boost ...

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

Arginine reduced Alzheimer's plaques and improved memory in mice, offering hope for future medical treatments.

For decades, the brain’s own immune cells have watched Alzheimer’s plaques accumulate and done almost nothing about it. Now a ...

Something fishy may be going on with a daily pill trusted by millions of Americans. Across the country, older adults have ...